NASDAQ:PMVP | Free Cash Flow | PMV Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$19.68M$0.00-$19.68M
2025-12-31-$17.19M$15,000.00-$17.2M
2025-03-31-$18.27M$4,000.00-$18.27M
2024-12-31-$16.66M$56,000.00-$16.72M
2024-03-31-$16.18M$594,000.00-$16.78M
2023-12-31-$12.09M$197,000.00-$12.28M
2023-03-31-$15.01M$156,000.00-$15.17M
2022-12-31-$15.32M$1.64M-$16.96M
2022-03-31-$18M$796,000.00-$18.79M
2021-12-31-$12.03M$262,000.00-$12.29M
2021-03-31-$12.9M$120,000.00-$13.02M
2020-12-31-$10.31M$57,000.00-$10.37M
2020-03-31-$8.14M$51,000.00-$8.19M
2019-12-31-$5.13M$0.00-$5.13M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$73.58M$29,000.00-$73.61M
2024-12-31-$51.28M$655,000.00-$51.94M
2023-12-31-$55.66M$962,000.00-$56.62M
2022-12-31-$63.76M$7.98M-$71.74M
2021-12-31-$46.57M$1.35M-$47.92M
2020-12-31-$32.74M$148,000.00-$32.89M
2019-12-31-$22.07M$109,000.00-$22.17M
2018-12-31-$15.18M$452,000.00-$15.63M